Canadian Strategy for Cancer Control (2019-2029)
The refreshed Canadian Strategy for Cancer Control is here. Based on input from more than 7,500 Canadians including healthcare leaders from across the country, the Strategy sets the course for a more equitable approach to cancer in Canada. No matter who we are or where we live, we should all have access to world-class cancer care for generations to come.
Discover more about the modernized Canadian Strategy for Cancer Control. Visit cancerstrategy.ca.
New Patient/Family Representative on the CCRA Advisory Board
Effective January 1st, 2024, CCRA welcomes Dr. Rosilene Kraft as the incoming patient/family representative on the CCRA Advisory Board. Most recently, Rosilene served on the 2023 PIP Working Committee and was cross-appointed to the conference Scientific Program Committee. Sh... Read More »
Effective January 1st, 2024, CCRA welcomes Dr. Rosilene Kraft as the incoming patient/family representative on the CCRA Advisory Board. Most recently, Rosilene served on the 2023 PIP Working Committee and was cross-appointed to the conference Scientific Program Committee. Sh... Read More »
New Leadership at TFRI
Effective August 1st, 2021, Dr. Jim Woodgett, PhD, FRSC, a senior scientist based at the Lunenfeld-Tanenbaum Research Institute (LTRI) at Sinai Health will become the new President and Scientific Director of The Terry Fox Research Institute... Read More »
Effective August 1st, 2021, Dr. Jim Woodgett, PhD, FRSC, a senior scientist based at the Lunenfeld-Tanenbaum Research Institute (LTRI) at Sinai Health will become the new President and Scientific Director of The Terry Fox Research Institute... Read More »